The global thin film drugs market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for thin film drugs in hospitals and drugstores. Hospitals are increasingly adopting new technologies such as electronic medical records (EMRs) and electronic health records (EHRs) which have led to an increase in the adoption of thin film drugs. Thin film drugs are also being used by patients who cannot swallow tablets or capsules due to various reasons such as dysphagia, esophageal cancer, or other diseases that affect swallowing ability.
Transdermal Film segment is expected to dominate the global thin film drug market during the forecast period owing to its high penetration rate among hospitals and drugstores across North America, Europe, Asia Pacific and Middle East & Africa regions. Oral Thin Film segment is expected to witness significant growth during the forecast period owing to its high penetration rate among hospitals across North America region.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of the global Thin Film Drugs market.
- Increasing awareness about the benefits of Thin Film Drugs over traditional drugs is also driving the growth of this market globally.
- The high cost associated with manufacturing thin film drugs has been a major restraint for this market globally, which can be overcome by technological advancements in drug delivery systems and drug manufacturing processes that are expected to reduce production costs significantly in future years 5) Lack of awareness about thin film drugs among physicians and patients has been another factor restraining growth in this market globally.
Industry Growth Insights published a new data on “Thin Film Drugs Market”. The research report is titled “Thin Film Drugs Market research by Types (Transdermal Film, Oral Thin Film, Others, Thin Film Drug), By Applications (Hospitals, Drugstores, Others), By Players/Companies GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec, Tapemark, Prestige Bands, Sun Pharma, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp, APR, Thin Film Drug”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Thin Film Drugs Market Research Report
By Type
Transdermal Film, Oral Thin Film, Others, Thin Film Drug
By Application
Hospitals, Drugstores, Others
By Companies
GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec, Tapemark, Prestige Bands, Sun Pharma, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp, APR, Thin Film Drug
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Thin Film Drugs Market Report Segments:
The global Thin Film Drugs market is segmented on the basis of:
Types
Transdermal Film, Oral Thin Film, Others, Thin Film Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Drugstores, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- LTS
- J&J
- Indivior
- Pfizer
- Sanofi
- Church & Dwight
- tesa Labtec
- Tapemark
- Prestige Bands
- Sun Pharma
- MonoSol
- BioDelivery
- Arx
- ZIM
- NAL Pharma
- AdhexPharma
- Aavishkar
- IntelGenx Corp
- APR
- Thin Film Drug
Highlights of The Thin Film Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transdermal Film
- Oral Thin Film
- Others
- Thin Film Drug
- By Application:
- Hospitals
- Drugstores
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thin Film Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thin film drugs are medications that are delivered to the body through a thin layer of material. This allows for quick and easy absorption into the bloodstream, which can lead to faster and more effective treatment.
Some of the major companies in the thin film drugs market are GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec, Tapemark, Prestige Bands, Sun Pharma, MonoSol, BioDelivery, Arx, ZIM, NAL Pharma, AdhexPharma, Aavishkar, IntelGenx Corp, APR, Thin Film Drug.
The thin film drugs market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Thin Film Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Thin Film Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Thin Film Drugs Market - Supply Chain
4.5. Global Thin Film Drugs Market Forecast
4.5.1. Thin Film Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Thin Film Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Thin Film Drugs Market Absolute $ Opportunity
5. Global Thin Film Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Thin Film Drugs Market Size and Volume Forecast by Type
5.3.1. Transdermal Film
5.3.2. Oral Thin Film
5.3.3. Others
5.3.4. Thin Film Drug
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Thin Film Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Thin Film Drugs Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Drugstores
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Thin Film Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Thin Film Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Thin Film Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Thin Film Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Thin Film Drugs Demand Share Forecast, 2019-2026
9. North America Thin Film Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Thin Film Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Thin Film Drugs Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Drugstores
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Thin Film Drugs Market Size and Volume Forecast by Type
9.7.1. Transdermal Film
9.7.2. Oral Thin Film
9.7.3. Others
9.7.4. Thin Film Drug
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Thin Film Drugs Demand Share Forecast, 2019-2026
10. Latin America Thin Film Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Thin Film Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Thin Film Drugs Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Drugstores
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Thin Film Drugs Market Size and Volume Forecast by Type
10.7.1. Transdermal Film
10.7.2. Oral Thin Film
10.7.3. Others
10.7.4. Thin Film Drug
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Thin Film Drugs Demand Share Forecast, 2019-2026
11. Europe Thin Film Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Thin Film Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Thin Film Drugs Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Drugstores
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Thin Film Drugs Market Size and Volume Forecast by Type
11.7.1. Transdermal Film
11.7.2. Oral Thin Film
11.7.3. Others
11.7.4. Thin Film Drug
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Thin Film Drugs Demand Share, 2019-2026
12. Asia Pacific Thin Film Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Thin Film Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Thin Film Drugs Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Drugstores
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Thin Film Drugs Market Size and Volume Forecast by Type
12.7.1. Transdermal Film
12.7.2. Oral Thin Film
12.7.3. Others
12.7.4. Thin Film Drug
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Thin Film Drugs Demand Share, 2019-2026
13. Middle East & Africa Thin Film Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Thin Film Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Thin Film Drugs Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Drugstores
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Thin Film Drugs Market Size and Volume Forecast by Type
13.7.1. Transdermal Film
13.7.2. Oral Thin Film
13.7.3. Others
13.7.4. Thin Film Drug
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Thin Film Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Thin Film Drugs Market: Market Share Analysis
14.2. Thin Film Drugs Distributors and Customers
14.3. Thin Film Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. LTS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. J&J
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Indivior
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Pfizer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sanofi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Church & Dwight
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. tesa Labtec
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Tapemark
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Prestige Bands
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sun Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. MonoSol
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. BioDelivery
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Arx
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. ZIM
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. NAL Pharma
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. AdhexPharma
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Aavishkar
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. IntelGenx Corp
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. APR
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
